Human Papillomavirus Detection by Hybrid Capture II and Residual or Recurrent High-Grade Squamous Cervical Intraepithelial Neoplasia after Large Loop Excision of the Transformation Zone (LLETZ)
Restricted accessResearch articleFirst published online March, 2005
Human Papillomavirus Detection by Hybrid Capture II and Residual or Recurrent High-Grade Squamous Cervical Intraepithelial Neoplasia after Large Loop Excision of the Transformation Zone (LLETZ)
The purpose of this study was to assess the association between highly-oncogenic types HPV DNA detection by Hybrid Capture II (HCII) and residual or recurrent high-grade cervical intraepithelial neoplasia (CIN 2 or 3) during the follow-up of women submitted to large loop excision of the transformation zone (LLETZ).
Study design
In this cohort study, 94 women submitted to LLETZ because of CIN 2 or 3 between March 2001 and September 2002 were followed up twice yearly until September 2003. Follow-up visits consisted of an interview regarding clinical, social and demographic characteristics complemented with gynecological examination with specimen collection for Pap test and HCII and colposcopy. Eighty-one patients attended the first visit (mean 4.8 months, range 3-6) and 75 the second visit (mean 10.9 months, range 7-17 months). McNemar's test to assess the variation of HPV DNA detection following LLETZ, odds ratios (OR) to evaluate the correlation between HPV DNA positivity and residual/recurrent CIN during follow-up, and logistic regression to assess the risk of residual/recurrent CIN were used.
Results
There was a strong and significant reduction in HPV detection after LLETZ (P <0.001). HPV DNA detection was correlated with residual/recurrent CIN at the first (OR = 103.4; 95% CI 5.5 to 1961.2) and second (OR = 12.7; 95% CI 1.1 to 345.5) follow-up visits. Multivariate analysis showed HPV persistence as a stand-alone risk factor for residual/recurrent CIN (OR = 50.3; 95% CI 3.8 to 663.1).
Conclusions
High risk HPV DNA detection decreased substantially after CIN treatment with LLETZ, but HPV persistence was strongly correlated with residual/recurrent CIN.
PrendivilleW., CullimoreJ., NormanS.: Large loop excision of the transformation zone (LLETZ): a new method of management for women with cervical intraepithelial neoplasia.Br J Obstet Gynecol, 96: 1054–1060, 1989.
2.
DugganB.D., FelixJ.C., MuderspachL.I., GebhardtJ.A., GroshenS., MorrowC.P., RomanL.D.: Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study.Am J Obstet Gynecol, 180: 276–282, 1999.
3.
EduardoA.M., DinhT.V., HanniganE.V., YandellR.B., SchnadigV.J.: Outpatient loop electrosurgical excision procedure for cervical intraepithelial neoplasia: can it replace cold knife conization?J Reprod Med, 41: 729–732, 1996.
4.
SoutterW.P., de Barros LopesA., FletcherA., MonaghanJ.M., DuncanI.D., ParaskevaidisE., KitchenerH.C.: Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia.Lancet, 349: 978–980, 1997.
5.
BollenL.J.M., Tjong-A-HungS.P., van der VeldenJ., MolB.W., ten KateF.W., ter ScheggetJ., BleckerO.P.: Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology.Gynecol Oncol, 72: 924–929, 1999.
6.
FlannellyG., LaughanH., JandialL., MannE., CampbellM., KirtchenerH.: A study of treatment failures following large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia.Br J Obstet Gynecol, 104: 718–722, 1997.
7.
GardeilF., Barry-WalshC., PrendivilleW., ClinchJ., TurnerM.: Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III.Obstet Gynecol, 89: 419–422, 1997.
8.
Mohamed-NoorK., QuinnM.A., TanJ.: Outcomes after surgical cold knife conization with complete and incomplete excision of abnormal epithelium: a review of 699 cases.Gynecol Oncol, 67: 34–38, 1997.
9.
ParaskevaidisE., LolisE., KoliopoulosG., AlamanosY., FotiouS., KitchenerH.: Cervical intraepithelial neoplasia outcomes after large loop excision with clear margins.Obstet Gynecol, 95: 828–831, 2000.
10.
ChuaK.L., HjerpeA.: Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri.Gynecol Oncol, 66: 108–113, 1997.
11.
NagaiY., MaehamaT., AsatoT., KanazawaK.: Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?Gynecol Oncol, 79: 294–299, 2000.
12.
NobbenhuisM.A.E., MeijerCJLM, van der BruleA.J.C., RozendaalL., VoorhorstF.J., BezemerP.D., VerheijenR.H., MeijerC.J.: Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia.Br J Cancer, 84: 769–801, 2001.
13.
ZielinskiG.D., RozendaalL., VoorhorstF.J., BerkhofJ., SnijdersP.J., RisseE.J., RunsinkA.P., de SchipperF.A., MeijerC.J.: HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3.Gynecol Oncol, 97: 67–73, 2003.
14.
SolomonD., DaveyD.D., KurmanR.J., MoriartyA., O'ConnorD., PreyM., RaabS., ShermanM., WilburD., WrightT.Jr., YoungN; Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda system - terminology for reporting results of cervical cytology.JAMA, 287: 2114–2119, 2002.
15.
LörinczA.T., CastleP.E., ShermanM.E., ScottD.R., GlassA.G., WacholderS., RushB.B., GravittP.E., SchusslerJ.E., SchiffmanM.: Viral load of human papillomavirus and risk of CIN 3 or cervical cancer.Lancet, 360: 288–289, 2002.
16.
ScullyR.E., BonfiglioT.A., KurmanR.J., SilverbergS.G., WilkinsE.J.: Histological typing of female genital tract tumors. World Health Organization - International histological classification of tumors, 2nd ed, Springier-Verlag, Berlin, 1994.
17.
AltmanD.G.: Practical statistics for medical research, 1st edition, pp 611, Chapman and Hall, London, 1991.
18.
HallS., LörinczA., ShahF., ShermanM.E., AbbasF., PaullG., KurmanP.J., ShahK.V.: Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.Gynecol Oncol, 62: 353–359, 1996.
19.
SunX.W., FerenczyA., JohnsonD., KoulosJ.P., LunguO., RichartR.M., WrightTCJr.: Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test.Am J Obstet Gynecol, 173: 1432–1437, 1995.
20.
FaitG., KupfermincM.J., DanielY., GevaE., RonI.G., LessingJ.B., Bar-AmA.: Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.Gynecol Oncol, 79: 177–180, 2000.
21.
SchiffmanM.H., BauerH.M., HooverR.N., GlassA.G., CadellD.M., RushB.B., ScottD.R., ShermanM.E., KurmanR.J., WacholderS.: Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.J Natl Cancer Inst, 85: 958–964, 1993.
22.
NuovoG.L., MoritzJ., KowalikA., ChalasE., KaplanB., MannW.: Human papillomavirus types and cervical squamous intraepithelial lesions that recur after cold-knife conization.Gynecol Oncol, 174: 937–942, 1992.
23.
ColganT.J., PercyM.E., SuriM., ShierR.M., AndrewsD.F., LickrishGM.Human papillomavirus infection of morphologically normal cervical epithelium adjacent to squamous dysplasia and invasive carcinoma.N Engl J Med, 315: 1052–1058, 1986.
24.
HolowatyP., MillerA.B., RohanT., ToT.: Natural history of dysplasia of the uterine cervix.J Natl Cancer Inst, 91: 252–258, 1999.
25.
ElfgrenK., BistoletiP., DillnerL., WallboomersJ.M., MeijerC.J., DillnerJ.: Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens.Am J Obstet Gynecol, 174: 937–942, 1996.
26.
IARC monographs on the evaluation of carcinogenic risks to humans. Vol 64. Human papillomaviruses.International Agency for Research on Cancer, Lyon, France, 1995.
27.
KjaerS.K., van der BruleA.J., PaullG., SvareE.I., ShermanM.E., ThomsenB.L., SuntumM., BockJ.E., PollP.A., MeijerC.J.: Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow-up study.BMJ, 325: 572–578, 2002.
28.
CostaS., de SimoneP., VenturoliS., CriccaM., ZerbiniM.L., MusianiM., TerzanoP., SantiniD., CristianiP., SyrjanenS.: Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.Gynecol Oncol, 90: 358–365, 2003.
